Rising Patent Disputes Ignite Post-Pandemic Pharmaceutical Industry Turmoil

As global attention shifts away from the COVID-19 pandemic, the underlying legal battles surrounding vaccine patents are intensifying. More than four years since clinical trials for COVID-19 vaccines commenced, the lucrative technology has led to numerous patent suits in the United States. These legal disputes are largely still in the early stages, yet they hold significant implications for the companies involved and the future of pharmaceutical innovation. To explore key cases and developments in this domain, click here.